Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets

Authors:

Igor A. Astsaturov, Steven J. Cohen, Paul F. Engstrom, Sherri Z. Millis

Background

Identification of new drug targets may extend treatment options for neuroendocrine tumors (NET) regardless of histologic classification or primary organ site.

Download Publication